Risks of unregulated use of alpha-melanocyte-stimulating hormone analogues: a review.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Risks of unregulated use of alpha-melanocyte-stimulating hormone analogues: a review.
- Published In:
- International journal of dermatology, 56(10), 975-980 (2017)
- Database ID:
- RPEP-03304
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-03304APA
Habbema, Louis; Halk, Anne Berthe; Neumann, Martino; Bergman, Wilma. (2017). Risks of unregulated use of alpha-melanocyte-stimulating hormone analogues: a review.. International journal of dermatology, 56(10), 975-980. https://doi.org/10.1111/ijd.13585
MLA
Habbema, Louis, et al. "Risks of unregulated use of alpha-melanocyte-stimulating hormone analogues: a review.." International journal of dermatology, 2017. https://doi.org/10.1111/ijd.13585
RethinkPeptides
RethinkPeptides Research Database. "Risks of unregulated use of alpha-melanocyte-stimulating hor..." RPEP-03304. Retrieved from https://rethinkpeptides.com/research/habbema-2017-risks-of-unregulated-use
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.